Tristel (LON:TSTL) Stock Price Up 3.3% – What’s Next?

Tristel plc (LON:TSTL)’s share price shot up 3.3% during mid-day trading on Thursday . The stock traded as high as GBX 404.95 ($5.13) and last traded at GBX 395 ($5.01). 46,028 shares traded hands during mid-day trading, a decline of 31% from the average session volume of 66,706 shares. The stock had previously closed at GBX 382.50 ($4.85).

Tristel Stock Performance

The company has a current ratio of 4.92, a quick ratio of 3.83 and a debt-to-equity ratio of 19.12. The firm has a market cap of £188.22 million, a PE ratio of 3,038.46 and a beta of 0.23. The stock’s 50 day moving average price is GBX 403.86 and its 200 day moving average price is GBX 433.72.

Tristel Increases Dividend

The business also recently declared a dividend, which will be paid on Friday, December 20th. Investors of record on Thursday, November 28th will be issued a GBX 8.28 ($0.10) dividend. This is an increase from Tristel’s previous dividend of $5.24. This represents a yield of 2.1%. The ex-dividend date is Thursday, November 28th. Tristel’s dividend payout ratio is currently 10,000.00%.

Insiders Place Their Bets

In other Tristel news, insider Elizabeth Dixon sold 50,000 shares of the stock in a transaction that occurred on Thursday, September 19th. The shares were sold at an average price of GBX 397 ($5.03), for a total value of £198,500 ($251,616.17). 4.89% of the stock is currently owned by insiders.

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.